© 2003 European Society of Cardiology
The epidemiological enigma of heart failure with preserved systolic function
Cardiovascular Medicine, National Heart and Lung Institute, Imperial College Charing Cross Campus, Fulham Palace Road, London SW3 6LY, UK
* Corresponding author. Tel.: +44-0-20-8846-7352; fax: +44-0-20-8383-5513. E-mail address: s.graves{at}imperial.ac.uk
| Abstract |
|---|
Background: Current epidemiological evidence suggests that the prevalence of preserved systolic function in patients with heart failure varies widely from 13 to 74%. This inconsistency suggests a lack of consensus as to what this condition really is and how it has been characterised for epidemiological studies.
Aims: In this review, we summarise and discuss the current understanding of the epidemiology of heart failure with preserved systolic function and the challenges that this raises.
Methods: Studies were identified from Medline and Embase Literature Database searches using the subject headings heart failure, diastolic heart failure, epidemiology, incidence, prevalence, diagnosis, prognosis and mortality.
Results: Sixty-one studies of congestive heart failure with preserved systolic function were reviewed. There is great diversity in the criteria used to determine whether heart failure is present, the patient population, the setting of the study and methods of evaluating left ventricular function. This makes epidemiological studies of prevalence, morbidity and mortality impossible to compare.
Conclusions: The diagnosis of this syndrome might be better defined in terms of symptoms, elevated neuro hormones and impaired cardiac workload. This would allow accurate identification of cases so that further research could be conducted to measure outcome and assess therapeutic benefit.
Key Words: Heart failure Preserved systolic function Epidemiology
Received August 21, 2002; Revised September 16, 2003; Accepted November 13, 2003
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Tzanetos, D. Leong, and R. C. Wu Office management of patients with diastolic heart failure Can. Med. Assoc. J., March 3, 2009; 180(5): 520 - 527. [Full Text] [PDF] |
||||
![]() |
J. McMurray, M. Petrie, K. Swedberg, M. Komajda, S. Anker, and R. Gardner CHAPTER 23 Heart Failure ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Adamopoulos, F. Zannad, R. Fay, A. Mebazaa, A. Cohen-Solal, L. Guize, Y. Juilliere, and F. Alla Ejection fraction and blood pressure are important and interactive predictors of 4-week mortality in severe acute heart failure Eur J Heart Fail, September 1, 2007; 9(9): 935 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. De Keulenaer and D. L. Brutsaert Systolic and diastolic heart failure: Different phenotypes of the same disease? Eur J Heart Fail, February 1, 2007; 9(2): 136 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bursi, S. A. Weston, M. M. Redfield, S. J. Jacobsen, S. Pakhomov, V. T. Nkomo, R. A. Meverden, and V. L. Roger Systolic and diastolic heart failure in the community. JAMA, November 8, 2006; 296(18): 2209 - 2216. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Thune, C. Carlsen, P. Buch, M. Seibaek, H. Burchardt, C. Torp-Pedersen, L. Kober, and on behalf of the DIAMOND investigators Different prognostic impact of systolic function in patients with heart failure and/or acute myocardial infarction Eur J Heart Fail, August 1, 2005; 7(5): 852 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Steendijk Heart failure with preserved ejection fraction. Diastolic dysfunction, subtle systolic dysfunction, systolic-ventricular and arterial stiffening, or misdiagnosis? Cardiovasc Res, October 1, 2004; 64(1): 9 - 11. [Full Text] [PDF] |
||||
![]() |
K. Dickstein Appearances can deceive: even brave hearts can fail Eur. Heart J., July 2, 2004; 25(14): 1181 - 1182. [Full Text] [PDF] |
||||
![]() |
M. Tendera The epidemiology of heart failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1_suppl): S2 - S6. [Abstract] [PDF] |
||||






